Botox (botulinum toxin) mediates which of the following actions: acetylation of mitochondrial proteins, activation of presynaptic receptors, hydrolysis of synaptic terminal proteins, hyperpolarization of inhibitory neurons, or inhibition of synaptic neurons?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanism of Action of Botulinum Toxin (Botox)

Botox mediates hydrolysis of synaptic terminal proteins, specifically cleaving SNARE complex proteins (SNAP-25, VAMP/synaptobrevin, and syntaxin) that are essential for acetylcholine release from presynaptic motor neurons. 1

Molecular Mechanism

Botulinum toxin functions as a zinc-endopeptidase that systematically disrupts neurotransmission through the following sequence: 1

  • Heavy chain binding: The toxin's heavy chain (approximately 100,000 daltons) binds to peripheral cholinergic nerve terminals, including neuromuscular junctions and postganglionic parasympathetic nerve endings 1

  • Receptor-mediated endocytosis: After binding, the toxin is internalized into the presynaptic neuron through receptor-mediated endocytosis 1, 2

  • Translocation and proteolytic cleavage: The toxin translocates to the cytosol where its light chain (approximately 50,000 daltons) cleaves specific SNARE complex proteins required for synaptic vesicle fusion 1, 3

  • Inhibition of acetylcholine release: This proteolytic cleavage prevents synaptic vesicles from fusing with the presynaptic membrane, thereby blocking acetylcholine release and preventing neurotransmitter exocytosis 1, 4, 3, 5

Serotype-Specific Targets

Different botulinum toxin serotypes cleave distinct proteins or different sites on the same protein: 3

  • Type A and E: Both cleave SNAP-25 but at different bonds, contributing to their dissimilar durations of muscle relaxation 3
  • Type B: Cleaves VAMP/synaptobrevin 3
  • The specific cleavage sites determine the clinical potency and duration of effect, with type A producing the most severe and prolonged paralysis 1

Clinical Consequence

The characteristic descending flaccid paralysis results from blocking acetylcholine transmission at the neuromuscular junction through inhibition of presynaptic acetylcholine release, not through postsynaptic receptor effects or neuronal hyperpolarization 1

Recovery occurs over weeks to months only after sprouting of new nerve terminals, as the proteolytic damage to SNARE proteins is irreversible 1, 6

Why Other Options Are Incorrect

  • Acetylation of mitochondrial proteins: No evidence supports this mechanism 1, 3
  • Activation of presynaptic receptors: Botox binds but does not activate receptors; it enters cells to cleave intracellular proteins 1, 2
  • Hyperpolarization of inhibitory neurons: The toxin does not alter membrane potential; it prevents vesicle fusion 1, 3
  • Inhibition of synaptic neurons: While this describes the clinical effect, the molecular mechanism is specifically protein hydrolysis, not direct neuronal inhibition 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Botulinum toxin A inhibits acetylcholine release from cultured neurons in vitro.

In vitro cellular & developmental biology. Animal, 1993

Guideline

Botulism Syndrome and Serious Systemic Side Effects of Botox

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.